RE: Big Blue day Today :)30 Sep 2022 10:20
Wait for an update, but having been here a number of years In would think this is almost like a 2.5 mini trial. Avion will want to fast track the dosing element, because this is a multi billion dollar segment of the market. I think in exchange Imm will cede the international rights of the drug, but the royalty payments will be significant. Although I stand by the significant chances of a takeover in whole, or part.